National Library of Medicine , "FDA Approves Ozempic (Semaglutide) as the Only GLP-1 RA to Reduce the Risk of Worsening Kidney Disease and Cardiovascular Death in Adults with Type 2 Diabetes and Chronic Kidney Disease." PR Newswire , "FDA Approves Wegovy (Semaglutide) for Adults with Obesity." Drugs.com , 2021, Fonseca, Vivian A., et al
Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431
Some med spas may prescribe GLP-1s without confirming whether you meet clinical guidelines like having a BMI of 30 or higher, or a related health condition such as type 2 diabetes
The treatment works by slowing digestion and reducing the rate at which the stomach empties, helping you feel fuller for longer
It is suitable for patients who need a custom formulation that isnt commercially available, only when it is prescribed by a healthcare professional